Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,795,576
-
Total 13F shares
-
4,728,085
-
Share change
-
-4,133,585
-
Total reported value
-
$122,931,140
-
Put/Call ratio
-
199%
-
Price per share
-
$26.00
-
Number of holders
-
71
-
Value change
-
-$84,661,047
-
Number of buys
-
56
-
Number of sells
-
14
Institutional Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q2 2014
As of 30 Jun 2014 Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) had 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,728,085 shares of stock of the company.
Largest 10 holders included FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., VANGUARD GROUP INC, BlackRock Fund Advisors, State Street Corp, BlackRock Institutional Trust Company, N.A., Wood Investment Counsel LLC, SANDLER CAPITAL MANAGEMENT, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, and JANE STREET GROUP, LLC.
This table shows 71 institutional shareholders of the security as of 30 Jun 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.